Orthopediatrics (KIDS) Total Debt Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | 6,920.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,920.97% |
| Dec 31, 2025 | 38.84% |
| Sep 30, 2025 | 35.83% |
| Jun 30, 2025 | 940.21% |
| Mar 31, 2025 | -85.01% |
| Dec 31, 2024 | 48,002.63% |
| Sep 30, 2024 | 9,042.25% |
| Jun 30, 2024 | 1,025.12% |
| Mar 31, 2024 | 1,017.45% |
| Dec 31, 2023 | 5.56% |
| Sep 30, 2023 | -15.07% |
| Jun 30, 2023 | -97.39% |
| Mar 31, 2023 | -13.85% |
| Dec 31, 2022 | -86.21% |
| Sep 30, 2022 | -12.62% |
| Jun 30, 2022 | 2,778.22% |
| Mar 31, 2022 | -11.55% |
| Dec 31, 2021 | -11.15% |
| Sep 30, 2021 | -10.69% |
| Jun 30, 2021 | -94.75% |
| Mar 31, 2021 | -94.60% |
| Dec 31, 2020 | -95.51% |
| Sep 30, 2020 | -94.31% |
| Jun 30, 2020 | -58.63% |
| Mar 31, 2020 | -0.40% |
| Dec 31, 2019 | 23.11% |
| Sep 30, 2019 | -1.09% |
| Jun 30, 2019 | 138.01% |
| Mar 31, 2019 | -16.43% |
| Dec 31, 2018 | -1.19% |
| Sep 30, 2018 | 181.79% |
| Dec 31, 2017 | 367.35% |